Long-term efficacy and tolerability of azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide in chronic kidney disease

Author:

Bakris George L.1ORCID,Zhao Lin2,Kupfer Stuart2,Juhasz Attila3,Hisada Michie2,Lloyd Eric2,Oparil Suzanne4

Affiliation:

1. University of Chicago Medicine; Chicago IL USA

2. Takeda Development Center Americas, Inc; Deerfield IL USA

3. GE Healthcare; Amersham UK

4. University of Alabama at Birmingham; Birmingham AL USA

Funder

Takeda Development Center Americas, Inc.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference24 articles.

1. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies;Lewington;Lancet,2002

2. Management of hypertension: evidence from the Blood Pressure Lowering Treatment Trialists’ Collaboration and from major clinical trials;Chalmers;Pol Arch Med Wewn,2009

3. Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults;Emdin;BMJ,2015

4. The kidney in hypertension;Sternlicht;Med Clin North Am,2017

5. Trends in blood pressure among adults with hypertension: United States, 2003 to 2012;Yoon;Hypertension,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3